Replies to post #756007 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

That's a fair statement GaryLot of us long termers will be more than elated to get out at anywhere close to 5.Any tumor agnostic is not happening under current management . If they stay at helm , FDA approval just for GBM by early 2027 is the best we can hope for 

[AAPL31415926]

Gary don't sell the company short. Merck gets $25 billion per year revenue from Keytruda. I think they'd be happy to pay $25B for Nwbo to extend their patent out another 10 years and prevent anyone else from having this treatment. Not to mention all the patents and Flaskworks. And that would probably equal at least $15 per share which I think most would be happy with.